Noventra Pharma | Growth Matrix 12mg - 3ml | Compound Peptide Pen
Advanced Multi-Pathway Metabolic Research Compound
Noventra Pharma Growth Matrix 12mg is an investigational hybrid peptide research compound studied in laboratory environments for its role in cellular signalling pathways, metabolic regulation mechanisms, and endocrine communication systems.
Hybrid peptide formulations are widely referenced in scientific research exploring multi-receptor interactions, energy balance regulation, and metabolic adaptation processes within controlled experimental models.
Developed as a 12mg (3ml) compound peptide pen, this formulation is designed for laboratory preparation and controlled research applications where multi-pathway metabolic signalling and peptide interaction studies are of scientific interest.
Noventra Pharma Growth Matrix 12mg Compound Peptide Pen (3ml)
• Hybrid peptide research compound studied in metabolic signalling models
• Investigated in cellular energy regulation and endocrine pathway research
• Of interest in multi-receptor interaction studies
• Explored in metabolic adaptation and energy homeostasis models
• 12mg (3ml) pen format designed for laboratory preparation use
• High-purity investigational formulation from Noventra Pharma
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
